CRVS financials
Corvus Pharmaceuticals (CRVS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CRVS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$105.00K | -$42.97M | -$15.28M | -0.53 |
| 2024 | $0.00 | $0.00 | -$27.55M | -$62.29M | -1.02 |
| 2023 | $0.00 | $0.00 | -$23.41M | -$27.03M | -0.56 |
| 2022 | $0.00 | $0.00 | -$32.56M | -$41.31M | -0.89 |
| 2021 | $0.00 | $0.00 | -$38.63M | -$43.24M | -1.03 |
| 2020 | $0.00 | $0.00 | -$43.76M | -$6.00M | -0.20 |